Poster No:
1271
Submission Type:
Late-Breaking Abstract Submission
Authors:
Brianna Austin1, Danielle Kurtin1, Katherine Herlinger1, Alexandra Hayes1, Alexandra Hand1, Leon Fonville1,2, Raymond Hill3, David Nutt1, Anne Lingford-Hughes1, Louise Paterson1
Institutions:
1Division of Psychiatry, Faculty of Medicine, Imperial College London, London, United Kingdom, 2Invicro London LLC, London, United Kingdom, 3Department of Metabolism, Digestion and Reproduction, Faculty of Medicine, Imperial College London, London, United Kingdom
First Author:
Brianna Austin
Division of Psychiatry, Faculty of Medicine, Imperial College London
London, United Kingdom
Co-Author(s):
Danielle Kurtin, PhD
Division of Psychiatry, Faculty of Medicine, Imperial College London
London, United Kingdom
Katherine Herlinger
Division of Psychiatry, Faculty of Medicine, Imperial College London
London, United Kingdom
Alexandra Hayes
Division of Psychiatry, Faculty of Medicine, Imperial College London
London, United Kingdom
Alexandra Hand
Division of Psychiatry, Faculty of Medicine, Imperial College London
London, United Kingdom
Leon Fonville
Division of Psychiatry, Faculty of Medicine, Imperial College London|Invicro London LLC
London, United Kingdom|London, United Kingdom
Raymond Hill
Department of Metabolism, Digestion and Reproduction, Faculty of Medicine, Imperial College London
London, United Kingdom
David Nutt
Division of Psychiatry, Faculty of Medicine, Imperial College London
London, United Kingdom
Louise Paterson, PhD
Division of Psychiatry, Faculty of Medicine, Imperial College London
London, United Kingdom
Introduction:
Opioid use disorder (OUD) poses a significant public health challenge, with >60% of individuals relapsing within six months post-treatment (Hayes et al., 2020). While harm reduction strategies and opioid substitution therapies have shown some success, improved relapse prevention strategies are needed. One way to develop more effective therapies is to improve the understanding of the neural underpinnings of OUD, and this can be done using fMRI. Here, we used Effective Connectivity (EC) to determine whether there is hierarchical control among functional networks disrupted by OUD, and whether whole-brain EC is an effective feature to between distinguish Healthy controls (HC) from people with OUD.
Methods:
Task-based fMRI data was collected from HC (n=22) and OUD participants receiving methadone (MD; n=25). Participants performed the Cue Reactivity (CR) and Monetary Incentive Delay (MID) tasks, which were chosen as they reliably engage reward/anti-reward pathways disrupted in OUD (Fonville et al., 2021). MRI data were acquired on a 3T Siemens Magnetom Verio scanner using a T2*-weighted echo-planar imaging sequence with GRAPPA and multiband acceleration factors:2 (Fonville et al., 2021). Data were preprocessed using fMRI Expert Analysis Tool (v6.0)(FEAT). Timeseries were extracted using the Schaefer atlas and Freesurfer, with select regions reassigned to the ventromedial network (VMN) to form a reward/anti-reward network. EC was quantified using large-scale nonlinear granger causality (Wismüller et al., 2021). To assess whether whole-brain EC is an effective distinguishing feature between HC vs MD participants, we used unsupervised hierarchal density-based spatial clustering with applications of noise (HDBSCAN). Dimensionality reduction of the EC matrices for clustering was performed with Uniform Manifold Approximation and Projection (UMAP) for subsequent clustering analysis. Trustworthiness and silhouette scores assessed UMAP's ability to represent the high-dimensional EC patterns in the reduced space. Permutation tests were used for statistical significance testing, with results considered significant at p<0.05 after max-T familywise correction.
Results:
We found significant EC differences between HC and MD participants across both tasks. In the MID task, 7.5% of all unique edges had significantly different EC between HC and MD participants, and about half of significant differences in EC showed HC had stronger connectivity than MD participants. In the CR task, 17.2% of all unique edges had significantly different EC between HC and MD participants, and most (>80%) of the significant differences in EC showed HC had stronger connectivity than MD participants. Edges with significantly stronger EC in HC vs MD participants were concentrated within and between the Control, Somatomotor, and Default Mode (DMN) networks. In the MID task, MD participants showed a greater proportion of edges with significantly higher EC in the VMN network as compared to HC and the CR task. UMAP quality assessment metrics (Trustworthiness score=0.72, silhouette score=64.2%) showed UMAP provided a moderately reliable representation of the high-dimensional EC patterns in the reduced space. However, EC patterns were unable to form distinct clusters that corresponded to clinical groups.


Conclusions:
EC was consistently weaker in MD participants compared with HC. Differences were concentrated in Control, Somatomotor, and Default Mode network. While these networks were dominant across both tasks, no one network drove dysfunction in others. Our findings suggest a key feature of OUD is impaired ability to dynamically regulate and shift between brain states. This network-level dysfunction implies OUD is not merely driven by an overactive reward system but rather compromised flexibility in engaging and transitioning between functional networks-particularly those involved in cognitive control and sensorimotor integration.
Disorders of the Nervous System:
Psychiatric (eg. Depression, Anxiety, Schizophrenia)
Modeling and Analysis Methods:
Classification and Predictive Modeling
Connectivity (eg. functional, effective, structural) 1
fMRI Connectivity and Network Modeling 2
Keywords:
Addictions
Computational Neuroscience
FUNCTIONAL MRI
Machine Learning
Psychiatric
1|2Indicates the priority used for review
By submitting your proposal, you grant permission for the Organization for Human Brain Mapping (OHBM) to distribute your work in any format, including video, audio print and electronic text through OHBM OnDemand, social media channels, the OHBM website, or other electronic publications and media.
I accept
The Open Science Special Interest Group (OSSIG) is introducing a reproducibility challenge for OHBM 2025. This new initiative aims to enhance the reproducibility of scientific results and foster collaborations between labs. Teams will consist of a “source” party and a “reproducing” party, and will be evaluated on the success of their replication, the openness of the source work, and additional deliverables. Click here for more information.
Propose your OHBM abstract(s) as source work for future OHBM meetings by selecting one of the following options:
I do not want to participate in the reproducibility challenge.
Please indicate below if your study was a "resting state" or "task-activation” study.
Other
Healthy subjects only or patients (note that patient studies may also involve healthy subjects):
Healthy subjects
Was this research conducted in the United States?
Yes
Are you Internal Review Board (IRB) certified?
Please note: Failure to have IRB, if applicable will lead to automatic rejection of abstract.
Yes, I have IRB or AUCC approval
Were any human subjects research approved by the relevant Institutional Review Board or ethics panel?
NOTE: Any human subjects studies without IRB approval will be automatically rejected.
Yes
Were any animal research approved by the relevant IACUC or other animal research panel?
NOTE: Any animal studies without IACUC approval will be automatically rejected.
Not applicable
Please indicate which methods were used in your research:
Structural MRI
For human MRI, what field strength scanner do you use?
3.0T
Which processing packages did you use for your study?
FSL
Free Surfer
Provide references using APA citation style.
[1] Madden, David J., and Jenna L. Merenstein. "Quantitative susceptibility mapping of brain iron in healthy aging and cognition. " NeuroImage 282 (2023): 120401.
[2] Bennett DA, Buchman AS, Boyle PA, et al. Religious Orders Study and Rush Memory and Aging Project. J Alzheimers Dis. 2018;64(s1):S161-S189.
[3] Abid R., Ridwan A.R., Wu Y., Niaz M.R., Zhang S., Evia A., Bennett D.A., Arfanakis K., Development of a high-resolution magnetic susceptibility template of the older adult brain in MIITRA space. Proc. Int. Soc. for Magn. Reson. in Med. (ISMRM) 2023.
[4] Ridwan, Abdur Raquib, et al. "Development and evaluation of a high performance T1‐weighted brain template for use in studies on older adults." Human Brain Mapping 42.6 (2021): 1758-1776.
[5] Niaz, M.R., Ridwan, A.R., Wu, Y., Zhang, S., Bennett, D.A.A. and Arfanakis, K. (2023), Interoperability of the MIITRA atlas with complementary atlases: development of a comprehensive array of gray matter labels. Alzheimer's Dement., 19: e081601. https://doi.org/10.1002/alz.081601
No